| Gene Symbol | BMP3 |
| Entrez ID | 651 |
| Uniprot ID | P12645 |
| Description | bone morphogenetic protein 3 |
| Chromosomal Location | chr4: 81,030,965-81,057,531 |
| Ontology | GO ID | GO Term | Definition | Evidence |
|---|---|---|---|---|
|
BP |
GO:0001501 |
skeletal system development |
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton). |
TAS |
|
BP |
GO:0001649 |
osteoblast differentiation |
The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone. |
IEA |
|
BP |
GO:0007267 |
cell-cell signaling |
Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions. |
TAS |
|
BP |
GO:0010862 |
positive regulation of pathway-restricted SMAD protein phosphorylation |
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways. |
IBA |
|
BP |
GO:0030509 |
BMP signaling pathway |
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
IBA |
|
BP |
GO:0040007 |
growth |
The increase in size or mass of an entire organism, a part of an organism or a cell. |
IEA |
|
BP |
GO:0042981 |
regulation of apoptotic process |
Any process that modulates the occurrence or rate of cell death by apoptotic process. |
IBA |
|
BP |
GO:0043408 |
regulation of MAPK cascade |
Any process that modulates the frequency, rate or extent of signal transduction mediated by the MAP kinase (MAPK) cascade. |
IBA |
|
BP |
GO:0048468 |
cell development |
The process whose specific outcome is the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate. |
IBA |
|
BP |
GO:0051216 |
cartilage development |
The process whose specific outcome is the progression of a cartilage element over time, from its formation to the mature structure. Cartilage elements are skeletal elements that consist of connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate. |
IEA |
|
BP |
GO:0060395 |
SMAD protein signal transduction |
The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell. |
IBA |
|
CC |
GO:0005615 |
extracellular space |
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
IBA |
|
CC |
GO:0070062 |
extracellular exosome |
A membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
IDA |
|
MF |
GO:0005102 |
receptor binding |
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
TAS |
|
MF |
GO:0005125 |
cytokine activity |
Functions to control the survival, growth, differentiation and effector function of tissues and cells. |
IBA |
|
MF |
GO:0005160 |
transforming growth factor beta receptor binding |
Interacting selectively and non-covalently with the transforming growth factor beta receptor. |
IBA |
|
MF |
GO:0008083 |
growth factor activity |
The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation. |
IEA |
|
MF |
GO:0070700 |
BMP receptor binding |
Interacting selectively and non-covalently with a BMP receptor. |
IDA |
| Domain ID | Description |
|---|---|
|
IPR001111 |
TGF-beta, propeptide |
|
IPR001839 |
Transforming growth factor-beta, C-terminal |
|
IPR015615 |
Transforming growth factor-beta-related |
|
IPR017197 |
Bone morphogenetic protein 3/3B |
|
IPR017948 |
Transforming growth factor beta, conserved site |
|
IPR029034 |
Cystine-knot cytokine |
| Pathway ID | Pathway Term | Pathway Source |
|---|---|---|
|
WP236 |
Adipogenesis |
WikiPathways |
| Pubmed ID | Author | Year | Title |
|---|---|---|---|
|
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
| Gene Symbol | Entrez ID | Uniprot ID | Score |
|---|---|---|---|
|
COL4A1 |
1282 |
P02462 |
0.52 |
|
COL4A2 |
1284 |
P08572 |
0.52 |
|
KDM1A |
23028 |
O60341 |
0.72 |
|
PRMT6 |
55170 |
Q96LA8 |
0.72 |
|
WFIKKN1 |
117166 |
Q96NZ8 |
0.72 |
|
WFIKKN2 |
124857 |
Q8TEU8 |
0.72 |
|
TGFB1 |
7040 |
P01137 |
0.52 |